Annovis Bio, Inc. (ANVS)
NYSE · Healthcare
Annovis Bio, Inc. Revenue 2020–2025
Annovis Bio, Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Annovis Bio, Inc. revenue for the quarter ending March 31, 2026 was 0.
- Annovis Bio, Inc. revenue for the twelve months ending March 31, 2026 was 0.
- Annovis Bio, Inc. annual revenue for 2025 was 0.
- Annovis Bio, Inc. annual revenue for 2024 was 0.
- Annovis Bio, Inc. annual revenue for 2023 was 0.
- Annovis Bio, Inc. annual revenue for 2022 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Annovis Bio, Inc. (ANVS) — Frequently Asked Questions
Annovis Bio, Inc. (ANVS) is a publicly traded US company. It has a market capitalization of $35M. Explore ANVS's stock price, financial statements, earnings history, margins and key ratios below.
What is Annovis Bio, Inc.'s market cap?
Annovis Bio, Inc. (ANVS) has a market capitalization of $35M.
What is the ANVS stock price?
ANVS trades at $1.72 (-2.82% on the day).
Is ANVS profitable?
In fiscal 2025, Annovis Bio, Inc. reported net income of -$29M.